JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Influence of SLC40A1 on Cytokine Interactions and Immune Infiltration in Glioblastoma

  • 0Department of Neurosurgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Neuromolecular Medicine +

|

May 15, 2024

|

May 15, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

High Slc40a1 expression in glioblastoma (GBM) correlates with a better prognosis. Slc40a1 influences the tumor immune microenvironment via cytokine interactions, suggesting potential for immunotherapeutic strategies.

Area Of Science

  • Oncology
  • Immunology
  • Molecular Biology

Background

  • Slc40a1 (Solute Carrier Family 40 Member 1) functions are studied in cancer.
  • Its specific role in primary glioblastoma (GBM) remains under-investigated.

Purpose Of The Study

  • To investigate the role of Slc40a1 in glioblastoma.
  • To explore the molecular mechanisms linking Slc40a1 expression to patient prognosis.

Main Methods

  • Bioinformatic analysis of TIMER and TCGA databases.
  • Gene Ontology (GO), KEGG pathway, and Gene Set Enrichment Analysis (GSEA).
  • Immune infiltration analysis, correlation studies, tissue microarray validation, and immunofluorescence.

Main Results

  • High Slc40a1 expression is associated with favorable prognosis in GBM patients.
  • Slc40a1 modulates the tumor immune microenvironment, particularly through interactions with Ccl14 and Il18.
  • Validation confirmed the correlation between high SLC40A1 protein levels and improved outcomes, alongside IL18 and CCL14 expression.

Conclusions

  • Slc40a1 plays a role in GBM pathogenesis by regulating the tumor immune microenvironment via Il18 and Ccl14.
  • Targeting Slc40a1 presents potential for novel immunotherapeutic interventions and prognostic assessments in GBM.

Keywords: